Latest Content

eServGlobal Lidco Group

Morning Note – 16 May 2019

eServGlobal (ESG): Corp Further encouraging HomeSend progress in Q1 | LiDCO (LID): Corp Q1 trading update – above expectations

 View

  • 16 May 19
  • -
  • -

ACP ASO SAV SDI

Morning Note – 15 May 2019

Armadale Capital (ACP): Corp Mahenge Liandu project update | Avesoro Resources (ASO): Corp Q1 financial results | Savannah Resources (SAV): Corp Significant new high grade lithium drilling results | Scientific Digital Imaging (SDI): Corp FY trading update

 View

  • 15 May 19
  • -
  • -

Hardide

Interim results

Significant progress continues to be made, especially in Aerospace, where today it has announced Airbus approval for use on the A380. Overall, the trading environment has been positive, although gross profit in H1 fell short due to a shift in the sales mix. A significant Oil & Gas customer temporarily changed its ordering patterns in Q2 (albeit demand from this customer has now started to recover). There was strong sales growth from other O&G customers and the flow control sector. The outlook statement points to FY revenue and EBITDA at the lower end of expectations, also including some H2 move-related costs. We peg back sales by £0.4m, which results in an adjusted PBT loss rising by £0.6m to £1.2m. Maintaining forecasts thereafter, we keep our 88p price target, recognising the exciting prospects for new customers and expansion over the next two years.

 View

  • 14 May 19
  • -
  • -

Shield Therapeutics

Europe underpins current valuation; await US approval

Shield Therapeutics is a commercial-stage pharmaceutical company whose lead compound, Feraccru, is marketed in some European markets for the treatment of iron deficiency, with or without anaemia. In a global market estimated to be worth c.£2.5bn, the recent head-to-head Phase IIIb trial, which showed Feraccru to be equivalent to the leading intravenous iron, positions Feraccru very favourably. The approval in the US, expected on 27 July, will be a key inflection point, the risk-adjusted value of which is not reflected in the current price at all. The NPV of Feraccru in Europe is c.81p, where it is currently marketed. The risk-adjusted NPV in the US is 229p. We initiate with a target price of 200p although FDA approval and subsequent licensing would see this rise to at least 250p.

 View

  • 14 May 19
  • -
  • -

HDD IDEA STX TEK

Morning Note – 14 May 2019

Hardide (HDD): Corp Interim results | Ideagen (IDEA): Corp Strong and consistent – full-year trading update | Shield Therapeutics (STX): Corp Europe underpins current valuation; await US approval | Tekcapital (TEK): Corp Launch of new eyewear line

 View

  • 14 May 19
  • -
  • -

CLEARSTAR

Morning Note – 13 May 2019

ClearStar (CLSU): Corp Switch to direct sales drives record revenue

 View

  • 13 May 19
  • -
  • -
 

finnCap Research and Daily Commentaries

Research Tree offers finnCap research, providing ongoing coverage of 264 shares , as well as macro-economic categories including: Commodities - Metals & Mining, Economic Data, and Indices and Markets. We offer 2085 reports from finnCap on Research Tree.

  • Research reports provided by finnCap

  • Companies covered by finnCap

  • Sectors covered by finnCap


Related Content

View the latest research on other companies in the sector. 

eServGlobal Lidco Group

Morning Note – 16 May 2019

eServGlobal (ESG): Corp Further encouraging HomeSend progress in Q1 | LiDCO (LID): Corp Q1 trading update – above expectations

 View

  • 16 May 19
  • -
  • -

ACP ASO SAV SDI

Morning Note – 15 May 2019

Armadale Capital (ACP): Corp Mahenge Liandu project update | Avesoro Resources (ASO): Corp Q1 financial results | Savannah Resources (SAV): Corp Significant new high grade lithium drilling results | Scientific Digital Imaging (SDI): Corp FY trading update

 View

  • 15 May 19
  • -
  • -

HDD IDEA STX TEK

Morning Note – 14 May 2019

Hardide (HDD): Corp Interim results | Ideagen (IDEA): Corp Strong and consistent – full-year trading update | Shield Therapeutics (STX): Corp Europe underpins current valuation; await US approval | Tekcapital (TEK): Corp Launch of new eyewear line

 View

  • 14 May 19
  • -
  • -

CLEARSTAR

Morning Note – 13 May 2019

ClearStar (CLSU): Corp Switch to direct sales drives record revenue

 View

  • 13 May 19
  • -
  • -

BYOT CHAR ELCO RBN VEL

Morning Note – 9 May 2019

Byotrol (BYOT): Corp FY trading update | Chariot Oil & Gas (CHAR): Corp Anchois satellites CPR | Elecosoft (ELCO): Corp A good first quarter in line with expectations | Robinson (RBN): Corp Positive AGM trading statement | Velocity Composites (VEL): Corp Encouraging trading update, resumption of forecasts

 View

  • 09 May 19
  • -
  • -

Avesoro Resources

Morning Note – 8 May 2019

Avesoro Resources (ASO): Corp Youga mine reserve 23% increase

 View

  • 08 May 19
  • -
  • -